A 36-year-old African American man with no medical historical past offered with a current historical past of cough and dyspnoea. Initial chest imaging revealed diffuse bilateral lung infiltrates. A subsequent HIV check resulted constructive, and he was presumptively identified with AIDS, later confirmed by a CD4 of 88 cells/mm3 Empiric remedy with trimethoprim-sulfamethoxazole was initiated for presumed Pneumocystis jirovecii pneumonia. The patient’s scientific standing deteriorated regardless of remedy. Further workup with chest CT, bronchoscopy and pores and skin biopsy led to a analysis of Kaposi sarcoma with pulmonary involvement. Highly energetic antiretroviral remedy remedy was initiated, alongside with plans to start out chemotherapy. However, the patient’s scientific standing quickly declined, resulting in respiratory failure and eventual demise.
This case underlines the significance of sustaining a broad differential in immunocompromised sufferers presenting with respiratory signs. Engineered crimson blood cells (RBCs) expressing viral receptors might be used therapeutically as viral traps as RBCs lack nuclei and different organelles required for viral replication. However, expression of viral receptors on RBCs is troublesome to attain since mature erythrocytes lack the mobile equipment to synthesize proteins. Here we present that the mix of a highly effective erythroid-specific expression system and transgene codon optimization yields excessive expression ranges of the HIV-1 receptors CD4 and CCR5, in addition to a CD4-glycophorin A (CD4-GpA) fusion protein in erythroid progenitor cells, which effectively differentiated into enucleated RBCs.
HIV-1 effectively entered RBCs that co-expressed CD4 and CCR5, however viral entry was not required for neutralization as CD4 or CD4-GpA expression in the absence of CCR5 was enough to potently neutralize HIV-1 and forestall an infection of CD4+ T-cells in vitro as a result of formation of high-avidity interactions with trimeric HIV-1 Env spikes on virions. To facilitate steady large-scale manufacturing of RBC viral traps, we generated erythroblast cell strains stably expressing CD4-GpA or ACE2-GpA fusion proteins, which produced potent RBC viral traps towards HIV-1 and SARS-CoV-2. Our in vitro outcomes counsel that this strategy warrants additional investigation as a potential remedy towards acute and persistent viral infections.
How Does HIV Persist Under Antiretroviral Therapy: A Review of the Evidence
HIV-1 is a retrovirus succesful of establishing viral reservoirs that stay steady for prolonged durations underneath suppressive antiretroviral remedy (ART). Immune dysfunction and latency are well-known to contribute to this longevity, however the respective roles of viral replication and latently contaminated (LI) cell proliferation underneath suppressive antiretroviral remedy (ART) have lengthy been controversial. This historic evaluate critically appraises the physique of proof relating to potential viral replication and proliferation of contaminated cells underneath ART. An ever-growing physique of genetic and phylogenetic research has demonstrated that HIV-infected cells are capable of proliferate and contribute to the longevity of the reservoir in ART-treated sufferers.
The position of ongoing replication stays controversial: it has been nicely established that HIV doesn’t endure evolution throughout ART or develop drug resistance, however some genetic, phylogenetic, and in vivo imaging research have prompt that there could also be ongoing replication regardless of this. The respective roles of viral replication and mobile proliferation in sustaining the LI reservoir stays an space of controversy. Elucidating these processes might enable us design interventions to cut back the dimensions of the LI reservoir, growing the size of remedy interruptions throughout which the virus will stay adequately suppressed, bringing us nearer to a useful treatment.
Novel experimental methods comparable to immuno-PET and digital droplet PCR (ddPCR) are more and more being employed, and these, alongside with speedy particle sorting methods at the moment in develop-ment, will likely be essential to completely reply this query. Persistent ache is frequent in HIV sufferers and breast most cancers (BC) survivors. The intention of this research was to match two patient teams with neuropathic ache (NP) relating to a number of psychological variables and Health-related Quality of Life. Although, remedy of ache is at all times deliberate individually, the information of the variations and similarities between the patient teams might assist us to grasp extra exactly the targets of the interventions for ache.
An evaluation of the reproducibility of reverse transcription digital PCR quantification of HIV-1
Viral load monitoring in human immunodeficiency virus kind 1 (HIV-1) an infection is usually carried out utilizing reverse transcription quantitative PCR (RT-qPCR) to look at response to remedy and establish the event of resistance. Traceability is achieved utilizing a calibration hierarchy traceable to the International Unit (IU). IU values are decided utilizing consensus settlement derived from estimations by totally different laboratories. Such a consensus strategy is critical because of the truth that there are at the moment no reference measurement procedures out there that may independently assign a reference worth to viral reference supplies for molecular in vitro diagnostic assessments.
) HIV-1 Gag-Pol polyprotein Antibody (Biotin) |
|
20-abx106322 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) HIV-1 Gag-Pol polyprotein Antibody (FITC) |
|
20-abx107735 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) HIV-1 Gag-Pol polyprotein Antibody (HRP) |
|
20-abx109153 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Gag Polyprotein (GAG) Antibody (Biotin) |
|
20-abx106336 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Gag Polyprotein (GAG) Antibody (FITC) |
|
20-abx107749 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (HRP)) Gag Polyprotein (GAG) Antibody (HRP) |
|
20-abx318947 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|
20-abx318948 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|
20-abx318949 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Gag Polyprotein (GAG) Antibody (HRP) |
|
20-abx317800 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Gag Polyprotein (GAG) Antibody (FITC) |
|
20-abx317801 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Gag Polyprotein (GAG) Antibody (Biotin) |
|
20-abx317802 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) Moloney murine leukemia virus Gag polyprotein (gag) |
|
1-CSB-EP356017MHK |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag) ,partial expressed in E.coli |
Moloney murine leukemia virus Gag polyprotein (gag) |
|
1-CSB-EP356017MHKe0 |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
|
|
Description: Recombinant Moloney murine leukemia virus Gag polyprotein(gag),partial expressed in E.coli |
 HIV-1 Gag p17 |
|
05-003 |
Sceti |
50 ug |
EUR 362 |
|
Description: The HIV-1 Gag p17 is available in Europe and for worldwide shipping via Gentaur. |
HIV-1 Gag p17 |
|
05-004 |
Sceti |
250 ug |
EUR 962 |
|
Description: The HIV-1 Gag p17 is available in Europe and for worldwide shipping via Gentaur. |
 HIV-1 Gag p24 |
|
05-005 |
Sceti |
50 ug |
EUR 362 |
|
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur. |
HIV-1 Gag p24 |
|
05-006 |
Sceti |
250 ug |
EUR 962 |
|
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur. |
 HIV-1 Gag p15 |
|
05-007 |
Sceti |
50 ug |
EUR 362 |
|
Description: The HIV-1 Gag p15 is available in Europe and for worldwide shipping via Gentaur. |
HIV-1 Gag p15 |
|
05-008 |
Sceti |
250 ug |
EUR 962 |
|
Description: The HIV-1 Gag p15 is available in Europe and for worldwide shipping via Gentaur. |
 HIV-1 Gag p55 |
|
05-009 |
Sceti |
50 ug |
EUR 401 |
|
Description: The HIV-1 Gag p55 is available in Europe and for worldwide shipping via Gentaur. |
HIV-1 Gag p55 |
|
05-010 |
Sceti |
250 ug |
EUR 962 |
|
Description: The HIV-1 Gag p55 is available in Europe and for worldwide shipping via Gentaur. |
 Moloney murine leukemia virus Gag polyprotein Antibody |
|
20-abx110606 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 HIV-1 gag recombinant antigen |
|
8934 |
Virostat |
100 ug |
EUR 452.38 |
|
Description: This is HIV-1 gag recombinant antigen for ELISA,WB. |
 HIV-1 p55 gag Protein |
|
20-abx260010 |
Abbexa |
-
EUR 2346.00
-
EUR 411.00
-
EUR 230.00
|
|
|
|
 HIV-I p24 gag Protein |
|
20-abx260279 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1609.00
|
|
|
|
) Moloney murine leukemia virus Gag polyprotein Antibody (HRP) |
|
20-abx109167 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 HIV-1 GAG P24 Recombinant Antigen |
|
00111-V-01mg |
Virogen |
0,1 mg |
EUR 267.5 |
|
|
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
HIV-1 GAG P24 Recombinant Antigen |
|
00111-V-1000ug |
Virogen |
1000 ug |
EUR 1282.5 |
|
|
|
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa |
 Recombinant HIV-1 Gag Protein [His] |
|
VAng-Lsx0260-100g |
Creative Biolabs |
100 µg |
EUR 594 |
|
Description: Recombinant HIV-1 Gag Protein, C-terminal 6xHis tagged, purified from E.coli. |
 HIV-1 gag p24 IIIB Protein |
|
abx060586-05mg |
Abbexa |
0.5 mg |
EUR 940 |
|
|
 Recombinant HIV-1 gag p17, p24 |
|
7-07675 |
CHI Scientific |
100µg |
Ask for price |
Recombinant HIV-1 gag p17, p24 |
|
7-07676 |
CHI Scientific |
500µg |
Ask for price |
Recombinant HIV-1 gag p17, p24 |
|
7-07677 |
CHI Scientific |
1000µg |
Ask for price |
 HIV-1 gag p17, p24 Protein |
|
20-abx260277 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1609.00
|
|
|
|
 [His]) Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|
VAng-Lsx0591-1mgEcoli |
Creative Biolabs |
1 mg (E. coli) |
EUR 3010 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|
VAng-Lsx0591-500gEcoli |
Creative Biolabs |
500 µg (E. coli) |
EUR 2039 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
Recombinant MMTV Gag Polyprotein (aa 2-99) [His] |
|
VAng-Lsx0591-50gEcoli |
Creative Biolabs |
50 µg (E. coli) |
EUR 1396 |
|
Description: Mouse Mammary Tumor Virus Gag Polyprotein (aa 2-99) [His], recombinant protein from E. coli. |
) HIV-1 gag Protein p24 (137-154) |
|
5-01316 |
CHI Scientific |
4 x 1mg |
Ask for price |
) HIV-1 gag Protein p24 (194-210) |
|
5-01317 |
CHI Scientific |
4 x 1mg |
Ask for price |
 Recombinant HIV-1 p24 gag, His Tag |
|
7-07609 |
CHI Scientific |
100µg |
Ask for price |
Recombinant HIV-1 p24 gag, His Tag |
|
7-07610 |
CHI Scientific |
500µg |
Ask for price |
Recombinant HIV-1 p24 gag, His Tag |
|
7-07611 |
CHI Scientific |
1000µg |
Ask for price |
 Recombinant HIV-1 gag p17, p24, gp120 |
|
7-07678 |
CHI Scientific |
100µg |
Ask for price |
Recombinant HIV-1 gag p17, p24, gp120 |
|
7-07679 |
CHI Scientific |
500µg |
Ask for price |
Recombinant HIV-1 gag p17, p24, gp120 |
|
7-07680 |
CHI Scientific |
1000µg |
Ask for price |
 HIV-1 gag p17, p24, gp120 Protein |
|
20-abx260274 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1609.00
|
|
|
|
HIV-1 gag Protein p24 (194-210) |
|
H-2986.0500 |
Bachem |
0.5mg |
EUR 273 |
|
Description: Sum Formula: C73H126N20O23S; CAS# [141281-67-6] |
HIV-1 gag Protein p24 (194-210) |
|
H-2986.1000 |
Bachem |
1.0mg |
EUR 466 |
|
Description: Sum Formula: C73H126N20O23S; CAS# [141281-67-6] |
HIV-1 gag Protein p24 (137-154) |
|
H-3006.0500 |
Bachem |
0.5mg |
EUR 273 |
|
Description: Sum Formula: C92H158N26O26S; CAS# [198636-98-5] |
HIV-1 gag Protein p24 (137-154) |
|
H-3006.1000 |
Bachem |
1.0mg |
EUR 466 |
|
Description: Sum Formula: C92H158N26O26S; CAS# [198636-98-5] |
) HIV-1 gag Protein p17 (76-84) |
|
H-5976.0001 |
Bachem |
1.0mg |
EUR 139 |
|
Description: Sum Formula: C44H72N10O15; CAS# [147468-65-3] net |
HIV-1 gag Protein p17 (76-84) |
|
H-5976.0005 |
Bachem |
5.0mg |
EUR 454 |
|
Description: Sum Formula: C44H72N10O15; CAS# [147468-65-3] net |
 Recombinant HTLV-2 gp 2 Gag-Pro-Pol Polyprotein |
|
VAng-Lsx0325-inquire |
Creative Biolabs |
inquire |
Ask for price |
|
Description: HTLV-2 gp 2 Gag-Pro-Pol Polyprotein, recombinant protein from E. coli. |
 Human HERV- K_7p22.1 provirus ancestral Gag polyprotein, ERVK6 E |
|
ELI-27186h |
Lifescience Market |
96 Tests |
EUR 824 |
 Recombinant HIV-1 gag p17-p24, gp41-gp120 |
|
7-07681 |
CHI Scientific |
100µg |
Ask for price |
Recombinant HIV-1 gag p17-p24, gp41-gp120 |
|
7-07682 |
CHI Scientific |
500µg |
Ask for price |
Recombinant HIV-1 gag p17-p24, gp41-gp120 |
|
7-07683 |
CHI Scientific |
1000µg |
Ask for price |
 HIV-1 gag p17-p24, gp41-gp120 Protein |
|
20-abx260273 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1609.00
|
|
|
|
 gag Antibody |
|
1-CSB-PA356017DA01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is Unconjugated. Tested in the following application: ELISA |
gag Antibody |
|
1-CSB-PA356017EA01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is Unconjugated. Tested in the following application: ELISA |
gag Antibody |
|
1-CSB-PA15019A0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Human immunodeficiency virus type 1 group M subtype B. This antibody is Unconjugated. Tested in the following application: ELISA |
 Recombinant HIV-1 gag p17 Protein, GST, E.coli-100ug |
|
QP12242-100ug |
EnQuireBio |
100ug |
EUR 218 |
 Recombinant HIV-1 gag p17 Protein, GST, E.coli-1mg |
|
QP12242-1mg |
EnQuireBio |
1mg |
EUR 1261 |
 Recombinant HIV-1 gag p17 Protein, GST, E.coli-500ug |
|
QP12242-500ug |
EnQuireBio |
500ug |
EUR 663 |
 Recombinant HIV-1 p24 gag Protein, Untagged, E.coli-100ug |
|
QP12257-100ug |
EnQuireBio |
100ug |
EUR 218 |
 Recombinant HIV-1 p24 gag Protein, Untagged, E.coli-1mg |
|
QP12257-1mg |
EnQuireBio |
1mg |
EUR 1261 |
 Recombinant HIV-1 p24 gag Protein, Untagged, E.coli-500ug |
|
QP12257-500ug |
EnQuireBio |
500ug |
EUR 663 |
 Recombinant HIV-1 p55 gag Protein, Untagged, Insect-100ug |
|
QP12258-100ug |
EnQuireBio |
100ug |
EUR 1859 |
 Recombinant HIV-1 p55 gag Protein, Untagged, Insect-10ug |
|
QP12258-10ug |
EnQuireBio |
10ug |
EUR 264 |
 Recombinant HIV-1 p55 gag Protein, Untagged, Insect-2ug |
|
QP12258-2ug |
EnQuireBio |
2ug |
EUR 155 |
 (isolates MAL/U455)) HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) |
|
5-01318 |
CHI Scientific |
4 x 5mg |
Ask for price |
 (isolates MAL / U455)) HIV-1 gag Protein p24 (65-73) (isolates MAL / U455) |
|
20-abx266081 |
Abbexa |
-
EUR 411.00
-
EUR 662.00
-
EUR 314.00
|
|
|
|
 HIV-1 gag p17-p24, gp41-gp120 (>95%)) Recombinant (E.Coli) HIV-1 gag p17-p24, gp41-gp120 (>95%) |
|
RP-542 |
Alpha Diagnostics |
100 ug |
EUR 286 |
HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) |
|
H-6222.0001 |
Bachem |
1.0mg |
EUR 176 |
|
Description: Sum Formula: C44H79N11O14S2; CAS# [334731-59-8] net |
HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) |
|
H-6222.0005 |
Bachem |
5.0mg |
EUR 611 |
|
Description: Sum Formula: C44H79N11O14S2; CAS# [334731-59-8] net |
 Recombinant HIV-1 gag p17-p24 Protein, Untagged, E.coli-100ug |
|
QP12243-100ug |
EnQuireBio |
100ug |
EUR 218 |
 Recombinant HIV-1 gag p17-p24 Protein, Untagged, E.coli-1mg |
|
QP12243-1mg |
EnQuireBio |
1mg |
EUR 1261 |
 Recombinant HIV-1 gag p17-p24 Protein, Untagged, E.coli-500ug |
|
QP12243-500ug |
EnQuireBio |
500ug |
EUR 663 |
 gag-pol Antibody |
|
1-CSB-PA15387A0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag-pol. Recognizes gag-pol from Human immunodeficiency virus type 1 group M subtype B. This antibody is Unconjugated. Tested in the following application: ELISA |
 gag Polyclonal Antibody |
|
A55695 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: Ask the seller for details |
gag Polyclonal Antibody |
|
A50708 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: kits suitable for this type of research |
gag Polyclonal Antibody |
|
A64434 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: kits suitable for this type of research |
 MuERVL-Gag Antibody |
|
48590-100ul |
SAB |
100ul |
EUR 333 |
MuERVL-Gag Antibody |
|
48590-50ul |
SAB |
50ul |
EUR 239 |
 Gag-Pol antibody |
|
70R-15487 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Gag-Pol antibody |
 Genome polyprotein Antibody |
|
1-CSB-PA333180LA01HFD |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|
1-CSB-PA714772LA01HYH |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|
1-CSB-PA18549A0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|
1-CSB-PA362073LA01HQD |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Unconjugated. Tested in the following application: ELISA |
 Genome Polyprotein Antibody |
|
20-abx109417 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Genome polyprotein Antibody |
|
20-abx300967 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 gag Antibody, HRP conjugated |
|
1-CSB-PA356017DB01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is HRP conjugated. Tested in the following application: ELISA |
 gag Antibody, FITC conjugated |
|
1-CSB-PA356017DC01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is FITC conjugated. Tested in the following application: ELISA |
 gag Antibody, Biotin conjugated |
|
1-CSB-PA356017DD01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is Biotin conjugated. Tested in the following application: ELISA |
gag Antibody, HRP conjugated |
|
1-CSB-PA356017EB01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is HRP conjugated. Tested in the following application: ELISA |
gag Antibody, FITC conjugated |
|
1-CSB-PA356017EC01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is FITC conjugated. Tested in the following application: ELISA |
gag Antibody, Biotin conjugated |
|
1-CSB-PA356017ED01MHK |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Moloney murine leukemia virus. This antibody is Biotin conjugated. Tested in the following application: ELISA |
gag Antibody, HRP conjugated |
|
1-CSB-PA15019B0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Human immunodeficiency virus type 1 group M subtype B. This antibody is HRP conjugated. Tested in the following application: ELISA |
gag Antibody, FITC conjugated |
|
1-CSB-PA15019C0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Human immunodeficiency virus type 1 group M subtype B. This antibody is FITC conjugated. Tested in the following application: ELISA |
gag Antibody, Biotin conjugated |
|
1-CSB-PA15019D0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag. Recognizes gag from Human immunodeficiency virus type 1 group M subtype B. This antibody is Biotin conjugated. Tested in the following application: ELISA |
 MuERVL-Gag Polyclonal Antibody |
|
A-2801 |
EpiGentek |
100 µl |
EUR 570.55 |
|
Description: kits suitable for this type of research |
 gag-pol Polyclonal Antibody |
|
A68246 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: Ask the seller for details |
 Retrovirus-related Gag Antibody |
|
48261-100ul |
SAB |
100ul |
EUR 333 |
Retrovirus-related Gag Antibody |
|
48261-50ul |
SAB |
50ul |
EUR 239 |
) Gag-Pol antibody (HRP) |
|
60R-2278 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Gag-Pol antibody (HRP) |
) Gag-Pol antibody (FITC) |
|
60R-2279 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Gag-Pol antibody (FITC) |
) Gag-Pol antibody (biotin) |
|
60R-2280 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Gag-Pol antibody (biotin) |
) Genome Polyprotein Antibody (Biotin) |
|
20-abx105887 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) Genome polyprotein Antibody (Biotin) |
|
20-abx106264 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) Genome polyprotein Antibody (FITC) |
|
20-abx107678 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
) Genome polyprotein Antibody (HRP) |
|
20-abx109095 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Genome Polyprotein Polyclonal Antibody |
|
A56130 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: Ask the seller for details |
Genome Polyprotein Polyclonal Antibody |
|
A56743 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: Ask the seller for details |
Genome Polyprotein Polyclonal Antibody |
|
A68253 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: Ask the seller for details |
Genome Polyprotein Polyclonal Antibody |
|
A68254 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: reagents widely cited |
Genome polyprotein Antibody (HRP) |
|
20-abx300968 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Genome polyprotein Antibody (FITC) |
|
20-abx300969 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Genome polyprotein Antibody (Biotin) |
|
20-abx300970 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Structural Polyprotein (VP2) Antibody |
|
abx224337-100ug |
Abbexa |
100 ug |
EUR 411 |
|
|
 HIV-1 gag p17, p24, GSt at the NT (>95%)) Recombinant (E.Coli) HIV-1 gag p17, p24, GSt at the NT (>95%) |
|
RP-554 |
Alpha Diagnostics |
100 ug |
EUR 286 |
 HIV-I p24 gag (77-423aa) and beta-Gal (>95%)) Recombinant (E.Coli) HIV-I p24 gag (77-423aa) and beta-Gal (>95%) |
|
RP-556 |
Alpha Diagnostics |
100 ug |
EUR 286 |
 Antibody) Feline Immunodeficiency Virus p24 gag Antigen (FIV p24 gag) Antibody |
|
abx413943-025mg |
Abbexa |
0.25 mg |
EUR 676 |
|
|
 gag-pol Antibody, HRP conjugated |
|
1-CSB-PA15387B0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag-pol. Recognizes gag-pol from Human immunodeficiency virus type 1 group M subtype B. This antibody is HRP conjugated. Tested in the following application: ELISA |
 gag-pol Antibody, FITC conjugated |
|
1-CSB-PA15387C0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag-pol. Recognizes gag-pol from Human immunodeficiency virus type 1 group M subtype B. This antibody is FITC conjugated. Tested in the following application: ELISA |
 gag-pol Antibody, Biotin conjugated |
|
1-CSB-PA15387D0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against gag-pol. Recognizes gag-pol from Human immunodeficiency virus type 1 group M subtype B. This antibody is Biotin conjugated. Tested in the following application: ELISA |
 gag Polyclonal Antibody, HRP Conjugated |
|
A55696 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: The best epigenetics products |
 gag Polyclonal Antibody, FITC Conjugated |
|
A55697 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: kits suitable for this type of research |
 gag Polyclonal Antibody, Biotin Conjugated |
|
A55698 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: fast delivery possible |
gag Polyclonal Antibody, HRP Conjugated |
|
A50709 |
EpiGentek |
100 µg |
EUR 570.55 |
|
Description: fast delivery possible |
Digital PCR (dPCR) is a approach that has the potential for use for this objective. In this paper, we examine the power of reverse transcriptase dPCR (RT-dPCR) to quantify HIV-1 genomic RNA with out calibration. Criteria investigated included the efficiency of HIV-1 RNA extraction steps, selection of reverse transcription strategy and choice of goal gene with assays carried out in each single and duplex format. We developed a protocol which was subsequently utilized by two unbiased laboratories as half of an exterior high quality assurance (EQA) scheme for HIV-1 genome detection. Our findings counsel that RT-dPCR might be used as reference measurement process to help the worth project of HIV-1 reference supplies to assist routine calibration of HIV-1 viral load testing by RT-qPCR.
